Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11)
Document Type
- Journal article (11)
Language
- English (11)
Keywords
- scleroderma (3)
- Autologous hematopoietic stem cell transplantation (2)
- B cells (2)
- Systemic sclerosis (2)
- cytokines (2)
- inflammation (2)
- rheumatoid arthritis (2)
- systemic sclerosis (2)
- B cell culture (1)
- CMV reactivation (1)
- Coronavirus Disease 2019 (1)
- GCA (1)
- Grave’s disease (1)
- Infectious complications (1)
- Interleukin-10 (1)
- Memory B cells (1)
- PMR (1)
- PU.1 (1)
- S100A8/S100A9 (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Sjögren’s syndrome (1)
- Th17 (1)
- Th9 (1)
- [18F]FDG PET/CT (1)
- acute respiratory distress syndrome (1)
- adverse events (1)
- autoimmune disease (1)
- autoimmune encephalitis (1)
- autoimmunity (1)
- autologous hematopoietic stem cell transplantation (1)
- autologous stem cell transplantation (1)
- c-reactive protein (1)
- calprotectin (1)
- common variable immunodeficiency (1)
- common variable immunodeficiency (CVID) (1)
- engraftment syndrome (1)
- fever (1)
- genital warts (1)
- giant cell arteritis (1)
- growth differentiation factor 15 (1)
- human papillomavirus (1)
- immune response (1)
- immunophenotyping (1)
- immunosuppression (1)
- inborn errors of immunity (IEIs) (1)
- inflammation marker (1)
- interleukin-9 (1)
- memory B cells (1)
- modified Rodnan skin score (mRSS) (1)
- mycophenolate (1)
- naïve B cells (1)
- polymyalgia rheumatica (1)
- primary immunodeficiencies (1)
- primary immunodeficiency (1)
- risk factor analysis (1)
- rituximab (1)
- tocilizumab (1)
- vasculature (1)
- vasculitis (1)
- γδ T cells (1)
Institute
- Medizinische Klinik und Poliklinik II (11) (remove)
Background
Autologous hematopoietic stem cell transplantation (aHSCT) is performed in patients with aggressive forms of systemic sclerosis (SSc). The profile of B cell reconstitution after aHSCT is not fully understood. The aim of this study was to investigate changes of B cell subsets and cytokine production of B cells in patients with SSc after aHSCT.
Methods
Peripheral blood of six patients with SSc was collected at defined intervals up to 16 months after aHSCT. Immunophenotyping was performed, and B cell function was determined by measuring cytokine secretion in supernatants of stimulated B cell cultures.
Results
Within 1 month after aHSCT, a peak in the percentage of CD38\(^{++}\)/CD10\(^+\)/IgD\(^+\) transitional B cells and CD38\(^{++}\)/CD27\(^{++}\)/IgD\(^−\) plasmablasts was detected. Long-term changes persisted up to 14 months after aHSCT and showed an increased percentage of total B cells; the absolute B cell number did not change significantly. Within the B cell compartment, an increased CD27/IgD\(^+\) naïve B cell percentage was found whereas decreased percentages of CD27\(^+\)/IgD\(^+\) pre-switched memory, CD27\(^+\)/IgD\(^−\) post-switched memory, and CD27\(^−\) /IgD\(^−\) double-negative B cells were seen after aHSCT. Cytokine secretion in B cell cultures showed significantly increased IL-10 concentrations 13 to 16 months after aHSCT.
Conclusion
A changed composition of the B cell compartment is present for up to 14 months after aHSCT indicating positive persisting effects of aHSCT on B cell homeostasis. The cytokine secretion profile of B cells changes in the long term and shows an increased production of the immune regulatory cytokine IL-10 after aHSCT. These findings might promote the clinical improvements after aHSCT in SSc patients.